Highly angiogenic CXCR4+CD31+ monocyte subset derived from 3D culture of human peripheral blood

Biomaterials

Volumn 34, Issue 8, 2013, Pages 1929-1941

  Hur, Jin ^a,b   Choi, Jae Il ^a,d   Yun, Ji Yeon ^a,d   Yoon, Chang Hwan ^a,c   Jang, Jae Hee ^a,d   Im, Seung Gyun ^a,b   Ko, Seung Bum ^a,d   Kang, Jin A ^a,d   Park, Jonghanne ^a,b   Lee, Sang Eun ^a,b   Kim, Ju Young ^a,b   Yang, Han Mo ^a,b   Park, Young Bae ^b   Kim, Hyo Soo ^a,b,d  

^a National Research Laboratory for Stem Cell Niche   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Angiogenesis; Hematosphere; Ischemic diseases; Microenvironment; Myeloid cells

Indexed keywords

3D CULTURE; ANGIOGENESIS; ANGIOGENIC CAPACITY; ANGIOGENIC CELLS; AUTOLOGOUS CELL; CELL SOURCES; CELLULAR COMPONENTS; CYTOKINES; EX VIVO EXPANSION; FLOW CYTOMETRY ANALYSIS; HEMATOSPHERE; HIND LIMBS; HUMAN PERIPHERAL BLOOD; IN-VIVO; MAGNETIC CELLS; MICROENVIRONMENTS; MYELOID CELLS; PERIPHERAL BLOOD; THERAPEUTIC EFFECTS; VASCULOGENIC; VESSEL FORMATION; VESSEL-LIKE STRUCTURES;

BLOOD; CELLS; DISEASE CONTROL;

CELL CULTURE;

CD31 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; MATRIGEL; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BLOOD; BONE MARROW CELL; CELL SELECTION; CELL STRUCTURE; FLOW CYTOMETRY; HINDLIMB; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOLECULAR INTERACTION; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; ANTIGENS, CD14; ANTIGENS, CD31; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; COLLAGEN; DRUG COMBINATIONS; HINDLIMB; HUMANS; ISCHEMIA; LAMININ; MICE; MICE, NUDE; MONOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; RECEPTORS, CXCR4; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84871527696     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.11.015     Document Type: Article

References (28)

1. Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002, 106:3009-3017.
2. Assmus B., Honold J., Schachinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355:1222-1232.
3. Byun K.H., Kim S.W. Is stem cell-based therapy going on or out for cardiac disease?. Korean Circ J 2009, 39:87-92.
4. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 2006, 354:1813-1826.
5. Flomenberg N., Devine S.M., Dipersio J.F., Liesveld J.L., McCarty J.M., Rowley S.D., et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 2005, 106:1867-1874.
6. Kang H.J., Kim H.S., Zhang S.Y., Park K.W., Cho H.J., Koo B.K., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004, 363:751-756.
7. Hur J., Park J., Lee S.E., Yoon C.H., Jang J.H., Yang J.M., et al. Human peripheral blood-born hematosphere as a niche for hematopoietic stem cell expansion. Cell Res 2011, 21:987-990.
8. Coffelt S.B., Lewis C.E., Naldini L., Brown J.M., Ferrara N., De Palma M. Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. Am J Pathol 2010, 176:1564-1576.
9. De Palma M., Venneri M.A., Galli R., Sergi Sergi L., Politi L.S., Sampaolesi M., et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005, 8:211-226.
10. Hattori K., Heissig B., Wu Y., Dias S., Tejada R., Ferris B., et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 2002, 8:841-849.
11. Conejo-Garcia J.R., Buckanovich R.J., Benencia F., Courreges M.C., Rubin S.C., Carroll R.G., et al. Vascular leukocytes contribute to tumor vascularization. Blood 2005, 105:679-681.
12. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004, 4:71-78.
13. Kang H.J., Kim J.Y., Lee H.J., Kim K.H., Kim T.Y., Lee C.S., et al. Magnetic bionanoparticle enhances homing of endothelial progenitor cells in mouse hindlimb ischemia. Korean Circ J 2012, 42:390-396.
14. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003, 33:401-406.
15. Hur J., Yang H.M., Yoon C.H., Lee C.S., Park K.W., Kim J.H., et al. Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation 2007, 116:1671-1682.
16. Yoon C.H., Hur J., Oh I.Y., Park K.W., Kim T.Y., Shin J.H., et al. Intercellular adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2006, 26:1066-1072.
17. Yoon C.H., Hur J., Park K.W., Kim J.H., Lee C.S., Oh I.Y., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005, 112:1618-1627.
18. Lee J.M., Choe W., Kim B.K., Seo W.W., Lim W.H., Kang C.K., et al. Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin. Biomaterials 2012, 33:8917-8927.
19. Oh I.Y., Yoon C.H., Hur J., Kim J.H., Kim T.Y., Lee C.S., et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood 2007, 110:3891-3899.
20. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004, 24:288-293.
21. Lin S.J., Huang P.H., Chen Y.H., Wang C.H., Chen J.S., Tsai H.Y., et al. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2009, 29:1179-1184.
22. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
23. Gerber H.P., Malik A.K., Solar G.P., Sherman D., Liang X.H., Meng G., et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 2002, 417:954-958.
24. Matsuda-Hashii Y., Takai K., Ohta H., Fujisaki H., Tokimasa S., Osugi Y., et al. Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor. Exp Hematol 2004, 32:955-961.
25. Pruijt J.F., van Kooyk Y., Figdor C.G., Lindley I.J., Willemze R., Fibbe W.E. Anti-LFA-1 blocking antibodies prevent mobilization of hematopoietic progenitor cells induced by interleukin-8. Blood 1998, 91:4099-4105.
26. Newman P.J., Newman D.K. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 2003, 23:953-964.
27. Rajesh M., Kolmakova A., Chatterjee S. Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells. Circ Res 2005, 97:796-804.
28. Winkler I.G., Sims N.A., Pettit A.R., Barbier V., Nowlan B., Helwani F., et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010, 116:4815-4828.